By Dr Lim Wei Juan, Consultant Cardiologist, KPJ Johor Specialist Hospital
Dr Lim Wei Juan, Consultant Cardiologist at KPJ Johor Specialist Hospital, has spoken at the Menarini Roundtable Discussion on Advances in the Management of Urticaria and Hypertension on 6 February 2026 at Cathay Restaurant, Vantage Bay.
During this exclusive medical roundtable, Dr Lim presented on:
🔎 “Rethinking Beta-Blockers in Hypertension Management”
Hypertension remains one of the leading risk factors for heart attack, stroke, heart failure, and kidney disease in Malaysia. With evolving international guidelines and new clinical evidence, the role of beta-blockers in blood pressure management continues to be refined.
In this session, Dr Lim will discuss:
- The latest updates in hypertension guidelines
- When beta-blockers are appropriate in modern practice
- Cardiovascular risk stratification
- Individualized treatment strategies
- Practical insights for optimizing patient outcomes
👨⚕️ About Dr Lim Wei Juan
Dr Lim Wei Juan is a Consultant Cardiologist with a strong clinical focus in:
- Hypertension management
- Coronary artery disease & angioplasty (PCI)
- Heart failure management
- Arrhythmia & cardiac risk assessment
- Preventive cardiology
Practicing at KPJ Johor Specialist Hospital, Dr Lim is committed to delivering evidence-based, patient-centred cardiovascular care tailored to each individual’s needs.
He is known for his clear explanations, thorough assessments, and holistic approach — helping patients understand their condition and make informed decisions about their heart health.
❤️ Why Early Hypertension Treatment Matters
High blood pressure is often called the “silent killer” because many patients have no symptoms until complications occur.
If you have:
- Persistent high blood pressure
- Family history of heart disease
- Diabetes or kidney disease
- Chest discomfort or shortness of breath
Early evaluation by a cardiologist can significantly reduce long-term cardiovascular risk.
📍 Consultation with Dr Lim Wei Juan
Dr Lim consults at:
KPJ Johor Specialist Hospital, Johor Bahru
高血压治疗新进展
重新审视β受体阻滞剂在现代心血管治疗中的角色
林威隽医生 – KPJ 柔佛专科医院心脏专科顾问医生
来自 KPJ Johor Specialist Hospital 的心脏专科顾问医生——林威隽医生，将于2026年2月6日出席Menarini医学圆桌论坛，主讲有关高血压管理的最新进展。
本次讲座主题：
🔎《重新思考β受体阻滞剂在高血压管理中的应用》
高血压是导致心脏病、中风、心衰竭及肾病的主要风险因素之一。随着国际治疗指南不断更新，β受体阻滞剂在高血压治疗中的角色也在不断优化。
林医生将分享：
- 最新高血压治疗指南重点
- 哪些患者适合使用β受体阻滞剂
- 心血管风险分层管理
- 个体化精准治疗策略
- 临床实践中的关键要点
👨⚕️ 关于林威隽医生
林威隽医生现任KPJ柔佛专科医院心脏专科顾问医生，专长包括：
- 高血压与心血管风险管理
- 冠心病与心导管介入治疗（PCI）
- 心力衰竭治疗
- 心律不整诊断与治疗
- 预防医学与心脏健康评估
林医生以循证医学为基础，结合个体化治疗理念，为患者提供全面而专业的心脏护理服务。
❤️ 为什么要尽早控制高血压？
高血压常被称为“沉默的杀手”，因为大多数患者在出现严重并发症之前并无明显症状。
若您有：
- 血压长期偏高
- 家族心脏病史
- 糖尿病或肾病
- 胸闷、气促等症状
建议及早咨询心脏专科医生，进行全面评估。
📍 看诊地点：
KPJ 柔佛专科医院（Johor Bahru）